Metastasis-directed Therapy for Oligometastases of Breast Cancer

NCT06135714 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

340

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Oligometastasis
Metastatic Breast Cancer

Interventions

DRUG: Systemic therapy for 12 weeks after primary registration
PROCEDURE: Radiation therapy (SBRT/conventional RT)
PROCEDURE: Surgery
DRUG: Same systemic therapy after secondary registration

Sponsor

Tokyo Medical and Dental University